Furthermore, HSP90-mediated downregulation of Toll-like receptor 4 (TLR4) exacerbates neutrophilic airway inflammation while simultaneously impairing glucocorticoid responsiveness, highlighting its dual role in perpetuating immune dysregulation and treatment resistance in COPD.28 This evidence concerns the gene HSP90AA1 and chronic obstructive pulmonary disease.